FRANKLIN
LAKES, N.J., Jan. 24,
2023 /PRNewswire/ -- The Board of Directors of BD
(Becton, Dickinson and Company) (NYSE: BDX) has declared a
quarterly dividend of $0.91 per
common share, payable on March 31,
2023 to holders of record on March
10, 2023. The indicated annual dividend rate is $3.64 per share.
About BD
BD is one of the largest global medical
technology companies in the world and is advancing the world of
health by improving medical discovery, diagnostics and the delivery
of care. The company supports the heroes on the frontlines
of health care by developing innovative technology, services
and solutions that help advance both clinical therapy for patients
and clinical process for health care providers. BD and
its 77,000 employees have a passion and commitment to help enhance
the safety and efficiency of clinicians' care delivery process,
enable laboratory scientists to accurately detect disease and
advance researchers' capabilities to develop the next generation of
diagnostics and therapeutics. BD has a presence in
virtually every country and partners with organizations around the
world to address some of the most challenging global health issues.
By working in close collaboration with customers, BD
can help enhance outcomes, lower costs, increase
efficiencies, improve safety and expand access to health care. For
more information on BD, please visit bd.com
or connect with us on LinkedIn at
www.linkedin.com/company/bd1/ and Twitter
@BDandCo.
Contacts:
|
|
|
|
Media:
|
Investors:
|
Troy Kirkpatrick
|
Francesca
DeMartino
|
VP, Public
Relations
|
SVP, Head of Investor
Relations
|
858.617.2361
|
201.847.5743
|
troy.kirkpatrick@bd.com
|
francesca.demartino@bd.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bd-board-declares-dividend-301729465.html
SOURCE BD (Becton, Dickinson and Company)